Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profile of knockdown of HMOX1 or/and pimozide-treated cancer cell lines

ABSTRACT: DRD2 antagonists are commonly used clinically for the treatment of psychiatric disorders. This study aimed to explore the antitumor effects of DRD2 antagonists on a variety of tumor entities. A DRD2 antagonist, pimozide, exhibited antitumor effects in pancreatic, colorectal, ovarian, and gastric cancers. HMOX1 was found to be highly expressed at both mRNA and protein levels, corroborating the results of profiling. Transcriptional profile of knockdown of HMOX1 or/and pimozide-treated cancer cell lines was showed then.

ORGANISM(S): Homo sapiens

SUBMITTER: Mei Mei

PROVIDER: E-MTAB-15496 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional profile of overexpression of HMOX1 or/and pimozide-treated cancer cell lines MIA PaCa-2, HCT 116, SK-OV-3, and AGS

Project description:DRD2 antagonists are commonly used clinically for the treatment of psychiatric disorders. This study aimed to explore the antitumor effects of DRD2 antagonists on a variety of tumor entities. A DRD2 antagonist, pimozide, exhibited antitumor effects in pancreatic, colorectal, ovarian, and gastric cancers. HMOX1 was found to be highly expressed at both mRNA and protein levels, corroborating the results of profiling. The treatment of pimozide and overexpression of HMOX1 experiments were conducted then.

2025-08-30 | E-MTAB-15495 | biostudies-arrayexpress

Transcriptional profile of pimozide-treated cancer cell lines MIA PaCa-2, PANC-1, HT-29, HCT 116, SK-OV-3, OVCAR-5, AGS, MKN45 and DMSO-treated (as control)

2025-08-01 | E-MTAB-15350 | biostudies-arrayexpress

Methylome of a low-grade invasive GIST

Project description:A low-grade invasive gastro-intestinal stromal tumour (GIST) was subjected to whole-genome sequencing as well as methylation profiling using Illumina 450K BeadChip array, in order to determine the minimal set of genomic and epigenomic alterations necessary to trigger the formation of invasive GIST. single-sample study, DNA extracted from fresh frozen tissue.

2014-08-01 | E-GEOD-55521 | biostudies-arrayexpress

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR1 as prognostic biomarkers independent of WHO grade

Project description:Meningiomas are frequent central nervous system tumors. Although most meningiomas are benign (WHO grade I) and curable by surgery, WHO grade II and III tumors remain therapeutically challenging due to frequent recurrence. Interestingly, relapse also occurs in some WHO grade I meningiomas. Hence, we investigated the transcriptional features defining aggressive (recurrent, malignantly progressing or WHO grade III) meningiomas in 144 cases. Meningiomas were categorized into non-recurrent (NR), recurrent (R), and tumors undergoing malignant progression (M) in addition to their WHO grade. Unsupervised transcriptomic analysis in 62 meningiomas revealed transcriptional profiles lining up according to WHO grade and clinical subgroup. Notably aggressive subgroups (R+M tumors and WHO grade III) shared a large set of differentially expressed genes (n=332; p<0.01, FC>1.25). In an independent multicenter validation set (n=82), differential expression of 10 genes between WHO grades was confirmed. Additionally, among WHO grade I tumors differential expression between NR and aggressive R+M tumors was af rmed for PTTG1, AURKB, ECT2, UBE2C and PRC1, while MN1 and LEPR discriminated between NR and R+M WHO grade II tumors. Univariate survival analysis revealed a significant association with progression-free survival for PTTG1, LEPR, MN1, ECT2, PRC1, COX10, UBE2C expression, while multivariate analysis identified a prediction for PTTG1 and LEPR mRNA expression independent of gender, WHO grade and extent of resection. Finally, stainings of PTTG1 and LEPR confirmed malignancy-associated protein expression changes. In conclusion, based on the so far largest study sample of WHO grade III and recurrent meningiomas we report a comprehensive transcriptional landscape and two prognostic markers. Comparative transcriptomic analysis of 62 low- and high-grade meningiomas

2016-02-15 | E-GEOD-74385 | biostudies-arrayexpress

Comparison of C57BL/6 and Dkk3-/- purified B1 and B2 cells

Project description:B2 cells were purified from spleen by CD19 Microbeads. B1 cells were purified from peritoneal cavity lavage by CD19 microbeads, followed by a depletion of CD23+ cells. RNA was prepared and differential gene expression analysis performed.

2014-08-19 | E-MTAB-2850 | biostudies-arrayexpress

Methylation data of 20 samples of human lung adenocarcinoma brain metastases

Project description:Methylation status of lung adenocarcinoma brain metastases was analyzed as part of an approach to defining the microenvironment

2020-01-04 | E-MTAB-8660 | biostudies-arrayexpress

RNA-seq analysis of primary human cancer associated fibroblasts isolated from breast cancer tissue

Project description:Primary human cancer associated fibroblasts (CAFs) were isolated and cultivated (up to passage 10). CAFs were sequenced to find differences in their respective gene expression patters.

2021-02-03 | E-MTAB-10075 | biostudies-arrayexpress

cDNA microarray Analysis of human iPSC-derived mesodermal progenitors treated with CHIR99021 compared to controls

Project description:The aim of this study was to unravel the effects of an initial WNT/β-catenin pulse on the in vitro differentiation of human iPSCs towards mesodermal progenitors and subsequent specification of chondrocytes. Therefore, mesodermal progenitors were generated from hiPSCs according to standard protocol (ctrl) or treated with 5 µM WNT/β-catenin agoinst CHIR99021 for 24h. To understand the long-term effects of short-initial WNT pulse on mesodermal differentiation, the global gene expression profile of day 14 mesodermal progenitors was compared.

2020-12-31 | E-MTAB-9226 | biostudies-arrayexpress

Compressed and non-compressed tissue-engineered HS-deficient and WT cartilage

Project description:Murine primary rib-cage chondrocytes (mRCs) were isolated from E15.5 WT and HS-deficient Ext1gt/gt mice and expanded for 6-7 days. Tissue-engineered cartilage was generated by a 14-day chondrogenic culture of mRCs at 5×10^5 cells per 25 µl agarose carrier. Engineered cartilage was exposed to cyclic unconfined compression for 3 hours: 10-minute cycles of dynamic unconfined compression (25 % dynamic compression at 1 Hz superimposed to 10 % static off-set) were intermitted by 10-minute breaks (10 % static off-set).

2021-03-14 | E-MTAB-10258 | biostudies-arrayexpress

Artificial mixtures of human and mouse DNA profiled on the Illumina Infinium EPICv2 BeadArray

Project description:DNA extracted from human A549 cell lines and a mouse cell line established from a KPC (KrasG12D/+/p53 fl/fl/LSL- Rosa26LSL-Cas9-EGFP) tumor mouse model. We mixed eight different fractions (0/100, 15/85, 30/70, 45/55, 60/40, 75/25, 90/10, and 100/0) of human and mouse DNA. The mixture was hybridized on the Illumina Infinium EPICv2 BeadArray at the Microarray Core Facility of the German Cancer Research Center.

2026-03-16 | E-MTAB-16743 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data